Dr. Hogan Shy will present a review of mental health within primary care, examining the current state of mental health in the general population and emphasizing the importance of addressing these issues.
Dr. Maureen O’Connor will explore the current state of California’s mental and behavioral health workforce, highlighting both challenges and opportunities.
Back by popular demand is our “Ask the Doctor” general meeting, and Dr. Rona Hu, MD, is our April presenter. She will speak briefly about schizophrenia and bipolar disorder, and then spend most of the evening answering your questions.
NAMI SCC Board Member Election for 2025-2026.
NAMI @ Work Presentation: This meeting will feature a presentation by NAMI-SCC’s Community and Media Relations Liaison, Tiffany Austin
NAMI-Santa Clara County offers FREE education programs designed to empower individuals living with mental illness and their families. These classes are led by NAMI-trained teachers who have their own life experience with mental illness. Our programs are offered throughout the year.
Santa Clara County is implementing Community Assistance, Recovery and Empowerment (CARE) Act on December 1, 2024. CARE Act is a new civil court process to access existing community-based services for those with untreated schizophrenia and other psychotic disorders.
Jeanette Langdell, Helpline Coordinator at NAMI-SCC, is our September 10 General Meeting presenter. Come learn the answers to questions such as: Why is it called a “Helpline”? Who calls us? What kinds of questions do we get? What kind of training does the staff receive?
Dr. Katherine Taylor is our June 11 “Ask the Doctor” general meeting presenter. Before she delves into your questions, Dr. Taylor will review recent trends in acute psychiatry being seen at El Camino Hospital. She will discuss the importance of awareness and education regarding the potential mental health risks associated with cannabis and methamphetamine use.…
Dr. Jacob Ballon is our May 14 general meeting presenter. Dr. Ballon will discuss the current pipeline of medications for schizophrenia, focusing on the medications in clinical trials at the Department of Psychiatry at Stanford University. He will touch on the different mechanisms and how that may make for fewer, or at least different, side effect profiles but also why these medications may work well with existing ones.
Dr. Karen Adams will discuss what is known about the links between major depression, generalized anxiety, and perimenopausal/menopausal mood instability. She will also address how menopause affects those with bipolar disorder and schizophrenia.